AtLaS was a single-arm pilot study that demonstrated promising efficacy and safety of treatment simplification to a dual regimen with atazanavir/ritonavir + lamivudine in virologically suppressed HIV-positive patients. Here, we report data from the 144 week follow-up.

Mondi, A., Fabbiani, M., Ciccarelli, N., Colafigli, M., D'Avino, A., Borghetti, A., Gagliardini, R., Cauda, R., De Luca, A., Di Giambenedetto, S., Efficacy and safety of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study, <<JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY>>, 2015; 70 (6): 1843-1849. [doi:10.1093/jac/dkv037] [http://hdl.handle.net/10807/68424]

Efficacy and safety of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study

Mondi, Annalisa;Fabbiani, Massimiliano;Ciccarelli, Nicoletta;Colafigli, Manuela;D'Avino, Alessandro;Borghetti, Alberto;Gagliardini, Roberta;Cauda, Roberto;De Luca, Andrea;Di Giambenedetto, Simona
2015

Abstract

AtLaS was a single-arm pilot study that demonstrated promising efficacy and safety of treatment simplification to a dual regimen with atazanavir/ritonavir + lamivudine in virologically suppressed HIV-positive patients. Here, we report data from the 144 week follow-up.
2015
Inglese
Mondi, A., Fabbiani, M., Ciccarelli, N., Colafigli, M., D'Avino, A., Borghetti, A., Gagliardini, R., Cauda, R., De Luca, A., Di Giambenedetto, S., Efficacy and safety of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study, <<JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY>>, 2015; 70 (6): 1843-1849. [doi:10.1093/jac/dkv037] [http://hdl.handle.net/10807/68424]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/68424
Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 40
  • ???jsp.display-item.citation.isi??? 38
social impact